Pyrotinib Maleate Tablets

This product is used to treat breast cancer.
It is contraindicated for patients who are allergic to pyrotinib or any of its ingredients.
Check liver function before treatment. Moderate to severe liver dysfunction may face the risk of liver toxicity and is not recommended.
Monitor the patient’s LVEF regularly to ensure that the LVEF is not lower than the lower limit of normal. … Details 
Full interpretation of pyrotinib maleate

Effects:
This product is used to treat breast cancer.
Dosage and administration:
The recommended dose of this product is 400 mg, once a day, orally within 30 minutes after a meal, and take the medicine at the same time every day. Take it continuously, and each 21 days is a cycle. The recommended dose of capecitabine is 1000 mg/m2, orally twice a day (once in the morning and evening, a total daily dose of 2000 mg/m2), taken within 30 minutes after a meal (taken once in the morning with pyrotinib), take it for 14 consecutive days and rest for 7 days, and each 21 days is a cycle. Treatment should continue until the disease progresses or intolerable toxic reactions occur. If the patient has adverse reactions during treatment, they can be managed by suspending, reducing or stopping the drug. The recommended dose adjustment of this product is 400, 320, and 240 mg/day. The efficacy data of the 240 mg/day dose is limited. If the dose needs to be further reduced to below 240 mg/day, terminate the treatment. The same drugs produced by different manufacturers may have inconsistent instructions. If you find inconsistencies in the drug instructions before taking the drug, please consult a doctor or pharmacist in time.
Drug contraindications:
Allergic to this product is prohibited and should be used with caution in patients with liver and kidney dysfunction
Related dosage forms:
Tablets